Remove Chronic Pain Remove Clinical Trials Remove Information
article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

The Centers for Disease Control and Prevention is seeking public comments on how Americans with chronic pain are successfully treating their symptoms. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.”

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Cannabis Law Report

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.

article thumbnail

Survey: Three Of Four Military Veterans Would Consider Using Medical Cannabis

NORML

Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate. Additional information is available from the NORML fact-sheet, “Marijuana and Veterans Issues,” here.

article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

article thumbnail

Press Release: Global Wellness Signs Definitive Agreement with Cannvalate Australia

Cannabis Law Report

Enters into the Chronic Pain Market with Psychedelics. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. Global Wellness Strategies Inc. ( billion in 2030.

article thumbnail

Cannabis Use In Active Athletes: Behaviors Related to Subjective Effects

Puff Puff Post

Nearly half of the athletes reported either acute or chronic pain. Cannabis may have a role in the daily health regimen for active athletes suffering from pain, anxiety, and insomnia. Our results need to be replicated in larger studies and clinical trials. reporting 6 or more hours per week of exercise.